Preliminary validation of the pica, ARFID and rumination disorder interview ARFID questionnaire (PARDI-AR-Q)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 802 KB, PDF-dokument

  • Rachel Bryant-Waugh
  • Casey M. Stern
  • Melissa J. Dreier
  • Micali, Nadia
  • Lucy J. Cooke
  • Megan C. Kuhnle
  • Helen Burton Murray
  • Shirley B. Wang
  • Lauren Breithaupt
  • Kendra R. Becker
  • Madhusmita Misra
  • Elizabeth A. Lawson
  • Kamryn T. Eddy
  • Jennifer J. Thomas

Background: The Pica, ARFID, and Rumination Disorder Interview (PARDI) is a structured interview that can be used to determine diagnosis, presenting characteristics, and severity across three disorders, including avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate the psychometric properties of a questionnaire focused specifically on ARFID (PARDI-AR-Q), which has the potential to provide related information with less participant burden. Methods: Adolescents and adults (n = 71, ages 14–40 years) with ARFID (n = 42) and healthy control participants (HC, n = 29) completed the PARDI-AR-Q and other measures. A subset of the ARFID group (n = 27) also completed the PARDI interview. Results: An exploratory factor analysis of proposed subscale items identified three factors corresponding to the ARFID phenotypes of avoidance based on the sensory characteristics of food, lack of interest in eating or food, and concern about aversive consequences of eating. Further analyses supported the internal consistency and convergent validity of the PARDI-AR-Q subscales, and subscale ratings on the questionnaire showed large and significant correlations (all p-values < 0.001; r’s ranging from 0.48 to 0.77) with the corresponding subscales on the interview. The ARFID group scored significantly higher than HC on all subscales. Furthermore, 90% of the ARFID group scored positive on the PARDI-AR-Q diagnostic algorithm while 93% of the HC scored negative. Conclusions: Though replication in larger and more diverse samples is needed, findings provide early support for the validity of the PARDI-AR-Q as a self-report measure for possible ARFID in clinical or research settings.

OriginalsprogEngelsk
Artikelnummer179
TidsskriftJournal of Eating Disorders
Vol/bind10
Udgave nummer1
Antal sider10
ISSN2050-2974
DOI
StatusUdgivet - dec. 2022
Eksternt udgivetJa

Bibliografisk note

Funding Information:
Research reported in this publication was supported by the Hilda and Preston Davis Foundation (JJT, KTE), the National Science Foundation (SBW, DGE-1745303), and the National Institutes of Health: National Institute of Mental Health R01MH108595 (JJT, EAL, NM), K24MH120568 (EAL), R01MH103402 (MM, KTE, EAL), R03MH103402 (LB), KL2TR002542 (LB), F31MH125495 (SBW), K23MH125143 (KRB); and the National Institute of Diabetes and Digestive and Kidney Diseases K23DK131334 (HBM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.

Publisher Copyright:
© 2022, The Author(s).

ID: 344906333